Koller v. Monsanto Company

CourtCourt of Appeals for the Ninth Circuit
DecidedMarch 27, 2025
Docket24-43
StatusUnpublished

This text of Koller v. Monsanto Company (Koller v. Monsanto Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Koller v. Monsanto Company, (9th Cir. 2025).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS MAR 27 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

SCOTT KOLLER; TIM No. 24-43 FERGUSON; RUBY CORNEJO; JOHN D.C. No. LYSEK, individually, and on behalf of the 3:22-cv-04260-MMC general public and those similarly situated, MEMORANDUM* Plaintiffs - Appellants,

v.

MONSANTO COMPANY; BAYER CROPSCIENCE LP; THE SCOTTS COMPANY LLC,

Defendants - Appellees,

and

SEAMLESS CONTROL LLC,

Defendant.

Appeal from the United States District Court for the Northern District of California Maxine M. Chesney, District Judge, Presiding

Argued and Submitted March 7, 2025 Pasadena, California

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. Before: TALLMAN, CLIFTON, and CHRISTEN, Circuit Judges.

Scott Koller, Tim Ferguson, Ruby Cornejo, and John Lysek (“Plaintiffs”)

bring this putative class action against defendants Monsanto Company, its parent

company, Bayer Cropscience LP (collectively “Monsanto”), and The Scotts

Company LLC. 1 They seek relief for alleged economic injuries suffered from

buying certain Monsanto weedkiller products sold in concentrated form under the

brand name Roundup.

Plaintiffs allege that the products at issue contain glyphosate, that glyphosate

is substantially certain to form N-Nitrosoglyphosate (“NNG”), that NNG is

carcinogenic, and that the NNG is substantially certain to form to a quantity level

that is dangerous and violates various identified regulations. Plaintiffs allege that,

as a result, they suffered economic injuries. They contend that their claims are

different from the many personal injury actions that have been brought concerning

Roundup products because this complaint seeks recovery only for economic

injuries allegedly suffered at the time of purchase, regardless of whether Plaintiffs

were physically harmed.

The district court granted Defendants’ initial motions to dismiss the

1 Plaintiffs also named Seamless Control LLC as a defendant. It is unclear whether Seamless remains to be treated as a defendant or appellee in this case. Defendants contend that Seamless was not served and no longer exists as a separate entity. Plaintiffs’ reply brief appears to acknowledge that Seamless has merged into Monsanto. That is a question to be resolved by the district court on remand.

2 24-43 Plaintiffs’ original Complaint and granted leave to amend. After Plaintiffs filed a

First Amended Complaint (“FAC”), Defendants filed new motions to dismiss. The

district court granted those motions, largely on grounds it cited in dismissing the

original Complaint, and denied further leave to amend.

A dismissal for failure to state a claim under Rule 12(b)(6) is reviewed de

novo. Prodanova v. H.C. Wainwright & Co., LLC, 993 F.3d 1097, 1105 (9th Cir.

2021). Allegations of material fact are taken as true and construed in the light most

favorable to the nonmoving party. Mudpie, Inc. v. Travelers Cas. Ins. Co. of Am.,

15 F.4th 885, 889 (9th Cir. 2021). To survive dismissal, these facts must state a

plausible claim to relief. Bell Atl. Corp. v. Twombly, 550 U.S. 544, 547 (2007).

This pleading standard does not require us to conclude that the complaint

states allegations that are probable. “[A] well-pleaded complaint may proceed even

if it strikes a savvy judge that actual proof of those facts is improbable, and ‘that a

recovery is very remote and unlikely.’” Id. at 556 (quoting Scheuer v. Rhodes, 416

U.S. 232, 236 (1974)).

We affirm in part and reverse in part. We conclude that Plaintiffs alleged

sufficient facts to plausibly state a claim for relief against Monsanto but also

conclude that the claims against Scotts were properly dismissed without leave to

amend.

3 24-43 1. Monsanto

The district court held that the FAC fell short of the plausibility requirement

in alleging two propositions: (1) that NNG in an amount above 1 part per million

(ppm) is carcinogenic and unsafe; and (2) that the products purchased by Plaintiffs

have formed NNG above 1 ppm or that such transformation is substantially certain

to occur. Plaintiffs dispute both holdings, and Defendants support both.

We conclude that the FAC contained sufficient allegations to make plausible

the claim that NNG levels above 1 ppm pose a serious safety hazard. It is true that

there are no applicable regulations that establish a firm 1 ppm limit for NNG. It is

also true that the establishment of a 1 ppm limit for NNG in consumer products

does not by itself establish that an NNG level above 1 ppm is necessarily

carcinogenic or otherwise unsafe. The FAC alleged, though, that Monsanto’s own

corporate representative testified that Monsanto is not aware of any regulatory

body in the world that allows more than 1 ppm of NNG in a glyphosate-based

herbicide. It alleged that several identified statements by the EPA support the

assertion that there should be concern for products containing NNG levels above

1 ppm. The FAC also explicitly referenced an expert declaration by Dr. Charles

Jameson, a chemist and environmental toxicologist, which concluded, with some

measure of scientific analysis and support, that NNG “poses a safety hazard to

4 24-43 customers at levels of 1 ppm or higher.” 2

To be clear, we do not hold that the submission of an expert opinion will

always be enough to establish plausibility, but in this instance, when combined

with other factual allegations, the FAC contains enough to make the relevant

contention plausible. The facts alleged in the complaint remain to be proven, of

course. We assume that, if the case continues, both Plaintiffs and Defendants will

muster more robust evidence. At this point, however, we cannot conclude, on de

novo review, that the facts alleged in the FAC were insufficient to get past the

plausibility requirement at the pleading stage.

Similarly, we conclude that the FAC alleged enough at this stage of the case

to make plausible the allegation that the level of NNG in the products purchased by

Plaintiffs will exceed 1 ppm during the products’ life. As Defendants fairly point

out, the FAC did not allege facts to establish that any of the products actually

purchased by any of the Plaintiffs, or to their knowledge by any other consumer,

contained NNG above the 1 ppm level. But the FAC alleged other facts to support

this contention, including that exposing glyphosate to nitrites could cause a

chemical reaction that creates NNG, and that Monsanto employees acknowledged

as much. The FAC alleged that containers of the products stored by consumer

2 The district court struck that declaration from the FAC but did not strike the FAC allegations regarding Dr. Jameson’s opinions. The district court drew that distinction explicitly in its order granting the motion to dismiss.

5 24-43 purchasers in garages posed risks of exposure to conditions, such as engine

exhaust, humidity, and heat, which could promote the formation of NNG. Further,

Plaintiffs alleged that Monsanto had discovered NNG at levels above 1 ppm in

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Wilson v. Hewlett-Packard Co.
668 F.3d 1136 (Ninth Circuit, 2012)
Gary Davis v. Hsbc Bank Nevada, N.A.
691 F.3d 1152 (Ninth Circuit, 2012)
Mesler v. Bragg Management Co.
702 P.2d 601 (California Supreme Court, 1985)
People Ex Rel. Mosk v. Lynam
253 Cal. App. 2d 959 (California Court of Appeal, 1967)
Graham v. Bank of America, N.A.
226 Cal. App. 4th 594 (California Court of Appeal, 2014)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Daniela Prodanova v. H.C. Wainwright & Co.
993 F.3d 1097 (Ninth Circuit, 2021)
Mudpie, Inc. v. Travelers Casualty Insurance
15 F.4th 885 (Ninth Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Koller v. Monsanto Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/koller-v-monsanto-company-ca9-2025.